AI
Strong Close to a Good Week for ENTB
Yes, it did very well this week. It held its value even on end-of-day trading, when a lot of the weaker souls take their margin profits and run like they stole something
Friday, to me, was probably the best day of the week, for a number of reasons, including that it looked like it had bumped up on 1.98 and would drop a bit on sell-offs, but a mini-rally took place and it improved over the last hour, which was exceptional but which also shouldn't have been surprising, given what ENTB is bringing to the game.
I was also really impressed because the broader 'main' markets (NYSE etc.) took a bit of a hit on news of that South Korean Navy ship sinking (for a while, it looked like the North Koreans had torpedoed it) and lost some value throughout the day because of it.
This is another reason why I like the biotech sector, because it's a bit less-dependent on news like what went on in the Yellow Sea or even on issues like big oil refinery problems and the like. I think that over the long run, if one has more patience than just for the quick strike daily or intra-day moves, these kinds of stocks can deliver a real chance at significant upward moves.
Like I said; I can see ENTB regaining its old 52-week high in the mid-sixes and then moving up from there. They've made two outstanding acquisitions to their clinical executive staff (with Carrier the newest signing) and the executive suite looks to have a solid plan that's positioning the company for solid success in the near term and long term. For me, that gives it a solid rating. I'm excited for Monday the 29th to get here, already (LOL!).
Yes, it did very well this week. It held its value even on end-of-day trading, when a lot of the weaker souls take their margin profits and run like they stole something
Friday, to me, was probably the best day of the week, for a number of reasons, including that it looked like it had bumped up on 1.98 and would drop a bit on sell-offs, but a mini-rally took place and it improved over the last hour, which was exceptional but which also shouldn't have been surprising, given what ENTB is bringing to the game.
I was also really impressed because the broader 'main' markets (NYSE etc.) took a bit of a hit on news of that South Korean Navy ship sinking (for a while, it looked like the North Koreans had torpedoed it) and lost some value throughout the day because of it.
This is another reason why I like the biotech sector, because it's a bit less-dependent on news like what went on in the Yellow Sea or even on issues like big oil refinery problems and the like. I think that over the long run, if one has more patience than just for the quick strike daily or intra-day moves, these kinds of stocks can deliver a real chance at significant upward moves.
Like I said; I can see ENTB regaining its old 52-week high in the mid-sixes and then moving up from there. They've made two outstanding acquisitions to their clinical executive staff (with Carrier the newest signing) and the executive suite looks to have a solid plan that's positioning the company for solid success in the near term and long term. For me, that gives it a solid rating. I'm excited for Monday the 29th to get here, already (LOL!).
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
